2Soldatos CR, Allaert FA, 0hta T, et al. How do individuals sleep around the world? Results from a single-day survey in tencountries. Sleep Med, 2005, 6: 5-13.
3Insomnia: assessment and management in primary care. National Heart, Lung, and Blood Institute Working Group on Insomnia. Am Fam Physician, 1999, 59: 3029-3038.
7Littner M, Hirshkowitz M, Kramer M, et al. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep, 2003, 26: 754-760.
8Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep, 2005, 28: 499-521.
9Morgenthaler T, Alessi C, Friedman L, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders : an update for 2007. Sleep, 2007, 30 : 519-529.
7Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA, 2004, 291: 2581-2590.
8Tylee A, Gastpar M, Lepine JP, et al. DEPRES Ⅱ (Depression Research in European Society Ⅱ ): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol, 1999, 14: 139-151.
9Shen J, Chung SA, Kayumov L, et al. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. Can J Psychiatry, 2006, 51 : 27-34.
10Schittecatte M, Dumont F, Machowski R, et al. Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology, 2002, 46 : 197-201.
